Fulgent Genetics Files Proxy Materials

Ticker: FLGT · Form: DEFA14A · Filed: Mar 26, 2025 · CIK: 1674930

Fulgent Genetics, Inc. DEFA14A Filing Summary
FieldDetail
CompanyFulgent Genetics, Inc. (FLGT)
Form TypeDEFA14A
Filed DateMar 26, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

Fulgent Genetics filed proxy docs for their annual meeting - shareholders vote soon.

AI Summary

Fulgent Genetics, Inc. filed a Definitive Additional Materials proxy statement on March 26, 2025. This filing relates to the company's proxy materials for its annual meeting, which will cover the fiscal year ending December 31, 2024. The company is incorporated in Delaware and headquartered in El Monte, California.

Why It Matters

This filing is important for shareholders as it contains information about the upcoming annual meeting, including proposals to be voted on and details about the company's governance.

Risk Assessment

Risk Level: low — This is a routine filing of proxy materials, not indicating any specific new risks or events.

Key Numbers

  • 2024-12-31 — Fiscal Year End (The proxy statement covers the fiscal year ending on this date.)
  • 20250326 — Filing Date (The date the Definitive Additional Materials were filed with the SEC.)

Key Players & Entities

  • Fulgent Genetics, Inc. (company) — Registrant
  • 4399 SANTA ANITA AVE (location) — Business Address
  • EL MONTE (location) — City
  • CA (location) — State
  • 91731 (location) — ZIP Code
  • Fulgent Diagnostics, Inc. (company) — Former Company Name

FAQ

What type of filing is this?

This is a DEFA14A filing, specifically 'Definitive Additional Materials' for Fulgent Genetics, Inc.

What is the primary purpose of a DEFA14A filing?

A DEFA14A filing is a proxy statement used to solicit shareholder votes for an upcoming meeting.

What is the fiscal year end for Fulgent Genetics, Inc. that this filing pertains to?

The filing pertains to the fiscal year ending December 31, 2024.

Where is Fulgent Genetics, Inc. headquartered?

Fulgent Genetics, Inc. is headquartered at 4399 Santa Anita Ave, El Monte, CA 91731.

Was there a previous name for Fulgent Genetics, Inc.?

Yes, the company was formerly known as Fulgent Diagnostics, Inc., with a name change date of May 17, 2016.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 26, 2025 regarding Fulgent Genetics, Inc. (FLGT).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.